Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
复制标题
DOI:
10.1016/j.kint.2016.12.037
复制
发表时间:
2017-07
影响因子:
19.6
通讯作者:
Neuwelt EA
中科院分区:
文献类型:
--
作者:
Toth GB;Varallyay CG;Horvath A;Bashir MR;Choyke PL;Daldrup-Link HE;Dosa E;Finn JP;Gahramanov S;Harisinghani M;Macdougall I;Neuwelt A;Vasanawala SS;Ambady P;Barajas R;Cetas JS;Ciporen J;DeLoughery TJ;Doolittle ND;Fu R;Grinstead J;Guimaraes AR;Hamilton BE;Li X;McConnell HL;Muldoon LL;Nesbit G;Netto JP;Petterson D;Rooney WD;Schwartz D;Szidonya L;Neuwelt EA
Contrast-enhanced magnetic resonance imaging (MRI) is a commonly used diagnostic tool. Compared to the standard gadolinium-based contrast agents, ferumoxytol (Feraheme, AMAG Pharmaceuticals, Waltham, MA), used as an alternative contrast medium, is feasible in patients with impaired renal function. Other attractive imaging features of intravenous (IV) ferumoxytol include a prolonged blood pool phase and delayed intracellular uptake. With its unique pharmacological, metabolic and imaging properties, ferumoxytol may play a crucial role in future MR imaging of the central nervous system (CNS), various organs outside the CNS, and the cardiovascular system. Preclinical and clinical studies have demonstrated the overall safety and effectiveness of this novel contrast agent with rarely occurring anaphylactoid reactions. The purpose of this review is to describe the general and organ specific properties of ferumoxytol, as well as the advantages and potential pitfalls associated with its use in MRI. In order to more fully demonstrate the applications of ferumoxytol throughout the body, an imaging atlas was created and is available as supplementary material online.
登录
查看更多内容
影响因子:
7.5
作者:
Alam, Shirjel R.;Shah, Anoop S. V.;Semple, Scott I. K.
通讯作者:
Semple, Scott I. K.
DOI:
10.1158/1078-0432.ccr-10-3420
发表时间:
2011-09-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Daldrup-Link HE;Golovko D;Ruffell B;Denardo DG;Castaneda R;Ansari C;Rao J;Tikhomirov GA;Wendland MF;Corot C;Coussens LM
通讯作者:
Coussens LM
影响因子:
5.7
作者:
D'Arceuil, Helen;Coimbra, Alexandre;Triano, Pamela;Dougherty, Margaret;Mello, Julie;Moseley, Michael;Glover, Gary;Lansberg, Maarten;Blankenberg, Francis
通讯作者:
Blankenberg, Francis
影响因子:
3.3
作者:
Blockley, N. P.;Jiang, L.;Gowland, P. A.
通讯作者:
Gowland, P. A.
影响因子:
8.3
作者:
Dosa, Edit;Tuladhar, Suchita;Neuwelt, Edward A.
通讯作者:
Neuwelt, Edward A.